Healthcare Utilization and Productivity After HSCT for Adolescents and Adults With SCD
Advances in Hematology · 2026-01 · 2026 (1)
DOI: 10.1155/ah/8419726 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Hematology, online erschienen am 28.05.2026. Verfasst von Samer Ghazi und 5 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Advances in hematopoietic stem cell transplantation (HSCT) for adolescents and adults with sickle cell disease (SCD) using non‐myeloablative (NMA) regimens have demonstrated promising outcomes in terms of mortality and reduction in disease/transplant‐related complications. Given these outcomes, assessing HSCT’s impact on healthcare use and productivity is key to guiding cost‐effectiveness decisions and informed treatment choices. In the current study, we compare healthcare utilization (HCU) and productivity loss in patients with SCD who have undergone HSCT to HSCT‐eligible patients but not transplanted yet. This was a cross‐sectional study. Participants reported the number of HCU events in the preceding 6 months in addition to their sociodemographic information. Generalized linear regression models were used to estimate the differences between the two groups. A total of 181 SCD patients aged 14 years or older (108 recipients and 73 candidates) completed a one‐time online survey. All measured HCU events (ED visits, blood transfusion, and hospitalization) were significantly lower among recipients compared to candidates ( p < 0.001). Likewise, recipients, compared to candidates, demonstrated significantly better Work Productivity and Activity Impairment (WPAI) scores ( p < 0.001). In conclusion, recipients of NMA HSCT reported significantly lower HCU and better productivity as compared to candidates. These findings indicate that NMA HSCT exhibited a positive impact on the socioeconomic aspects of their life and provide implications into health policy determinations, decision makers, and healthcare providers for the optimal use of the NMA HSCT in adolescents and adults with SCD.
Zitieren
APA
Ghazi, S., Mayo, S. J., Alzharani, M., Damlaj, M., Kumar, R., & Metcalfe, K. A. (2026). Healthcare Utilization and Productivity After HSCT for Adolescents and Adults With SCD. Advances in Hematology, 2026(1). https://doi.org/10.1155/ah/8419726
Vancouver
Ghazi S, Mayo SJ, Alzharani M, Damlaj M, Kumar R, Metcalfe KA. Healthcare Utilization and Productivity After HSCT for Adolescents and Adults With SCD. Advances in Hematology. 2026;2026(1). doi:10.1155/ah/8419726
BibTeX
@article{Ghazi2026,
author = {Ghazi, Samer and Mayo, Samantha J. and Alzharani, Mohsen and Damlaj, Moussab and Kumar, Rajat and Metcalfe, Kelly A.},
title = {Healthcare Utilization and Productivity After HSCT for Adolescents and Adults With SCD},
journal = {Advances in Hematology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ah/8419726}
}
EUVIMED